VAERS reports by lot

GSK Varicella/Shingles lot 27J4P: VAERS reports

71 VAERS reports list lot 27J4P as a GSK Varicella/Shingles vaccine, received between 2018-10-16 and 2021-12-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
71
Reports
0%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction6425%
General / Systemic (non-local)6124%
Neurological3112%
Dermatological (non-injection-site)3012%
Musculoskeletal2510%
Gastrointestinal125%
Respiratory94%
Allergic / Anaphylactic73%
Cardiac / Cardiovascular62%
Psychiatric / Neuropsychiatric62%
Thrombotic / Hematological10%
Autoimmune / Immune-mediated10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
New York5
South Carolina4
Texas4
Florida4
Minnesota3
Missouri3
Illinois3
North Carolina3
Pennsylvania3
Michigan3
New Hampshire3

Reports by month received

2018-1016
2018-1123
2018-1218
2019-013
2019-023
2019-031
2019-041
2019-051
2019-072
2019-102
2021-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.